Study
Synbiotics May Improve Constipation in Older Adults
A 4-week study found that a synbiotic supplement increased bowel movement frequency and improved gut transit time in seniors with constipation.
Summary
In plain language
A recent study explored the effects of a synbiotic supplement, combining probiotics and prebiotics, on constipation in adults aged 60 and older. The researchers discovered that after four weeks, participants taking the synbiotic supplement experienced more frequent bowel movements and faster digestive transit times compared to those taking a placebo. These benefits even persisted for two weeks after stopping the supplement. This is significant because constipation can affect quality of life and overall health, particularly in older adults. While the study shows promise, it's essential for seniors to discuss new supplements with their healthcare providers to ensure safety and effectiveness.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a randomized, double-blind, placebo-controlled trial involving older adults experiencing functional constipation. Participants were split into two groups: one received a synbiotic supplement, and the other a placebo, over a four-week period.
The synbiotic group showed increased bowel movement frequency and reduced gut transit time, with effects lasting even two weeks post-intervention.
Gut microbiota analysis revealed an increase in beneficial bacteria in those taking the synbiotic supplement.
The study's limitations include the small sample size and short duration, which means more research is needed for broader conclusions.
Seniors considering synbiotics should discuss with their healthcare providers to tailor interventions to their specific needs and conditions.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Synbiotics May Improve Constipation in Older Adults
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 26, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its rigorous randomized controlled trial design, strong bias control measures, and comprehensive statistical methods. Transparency was ensured through pre-registration and data sharing. The study directly targeted older adults, aligning with the user-specified population. However, the lack of replication evidence and unspecified journal quality limited the overall score.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized controlled trial evaluated the efficacy of a 4-week synbiotic intervention (BL-99/FOS) in older adults with functional constipation, showing improved bowel movements and gut microbiota diversity.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.